Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy. MedStar authors:
  • Hui, Adrian C
PMID:
  • 24797495
Year: 2014
Citation:
  • Can. j. diabetes. 38(4):269-72, 2014 Aug.
  • Canadian Journal of Diabetes. 38(4):269-72, 2014 Aug.
Institution:
  • MedStar Union Memorial Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Hui AC, Lull ME, Lyons-Patterson J, Traina AN, Zahorian TM
DOI:
Add to cart
2.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27650977
Year: 2016
Citation:
  • Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
DOI:
Add to cart
Pages

Powered by Koha